A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects.
PHASE1CompletedINTERVENTIONAL
Enrollment
48
Participants
Timeline
Start Date
November 29, 2022
Primary Completion Date
July 24, 2023
Study Completion Date
July 24, 2023
Conditions
Healthy Volunteers
Interventions
DRUG
JS1-1-01
Oral tables
DRUG
Placebo
Oral tables
Trial Locations (1)
Unknown
Shanghai Mental Health Center, Shanghai
All Listed Sponsors
lead
Tasly Pharmaceutical Group Co., Ltd
INDUSTRY
NCT05656274 - A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects. | Biotech Hunter | Biotech Hunter